Strictly follow policy requirements, implement quality work, and consolidate drug safety -- Our company participated in the dissemination meeting on the implementation of the supervision and management regulations for the main responsibility of quality and safety.

To further disseminate laws, regulations, and policies on drug production supervision, urge enterprises to implement their primary responsibilities for quality and safety, and safeguard the bottom line of drug quality and safety, On March 21, the "Dissemination Meeting on the Supervision and Management Regulations for Drug, Medical Device, and Cosmetic Enterprises to Implement the Primary Responsibility for Quality and Safety," hosted by the Comprehensive Department, Drug Supervision Department, Medical Device Supervision Department, and Cosmetics Supervision Department of the National Medical Products Administration (NMPA), was held as scheduled through offline training and online live streaming. Our company's leadership attached great importance to this training meeting, and General Manager Yao Xiaodong, along with personnel from relevant positions, participated in the entire meeting and studied diligently through online learning!

(Photo of the meeting scene)

The meeting officially opened with a speech by Wu Shaozhen, Chairman of the China Health Media Group! At the meeting, Yuan Lin, Director of the Drug Supervision Department of the NMPA, gave a detailed interpretation of the "Supervision and Management Regulations for the License Holder of Marketed Drugs to Implement the Primary Responsibility for Drug Quality and Safety," recently issued and implemented by the NMPA. Wang Zhexiong, Director of the Medical Device Supervision Department of the NMPA, Li Jinju, Director of the Cosmetics Supervision Department of the NMPA, and Shao Rong, Executive Dean of the Institute of Drug Regulatory Science at China Pharmaceutical University, respectively, disseminated the "Supervision and Management Regulations for Enterprises to Implement the Primary Responsibility for Medical Device Quality and Safety," "Supervision and Management Regulations for Enterprises to Implement the Primary Responsibility for Cosmetic Quality and Safety," and "Supervision and Management Regulations for the License Holder of Marketed Drugs to Implement the Primary Responsibility for Drug Quality and Safety," and other relevant laws and regulations on drug production. The meeting required enterprises to further strengthen their awareness of regulations, quality, and primary responsibilities, establish a bottom-line and risk-based mindset, and strictly implement the requirements of "two lists, two reports, and one commitment," and implement the primary responsibility for drug quality and safety and its supervision and management regulations in accordance with the law.

Through this training, the company's trainees have a comprehensive understanding of the new regulations, which has greatly promoted their ability to implement the primary responsibility for drug quality and safety in their future work, helping the company better implement GMP and better guarantee drug quality and safety!

Our company has always attached great importance to drug quality and safety. The company's senior management has always regarded drug quality and safety as a top priority. Through long-term exploration, the company has established a complete, scientific, standardized, and rigorous quality control system, creating a full-chain quality traceability system from material sources to the end market, and firmly establishing a drug quality and safety guarantee line. We are well aware that enterprises are the primary responsible parties for drug quality and safety. Next, we will further enhance our awareness, implement the regulations on the primary responsibility for quality and safety, continuously improve and optimize the quality management system, strengthen control over the production and operation process and product quality, and ensure that production and operation remain legal and compliant! We will resolutely fulfill our mission of "making high-quality drugs for people around the world!"